Amisulpride Injection

215 interactions 155 cited references
Also sold as: Barhemsys Barhemsys®
About Amisulpride Injection

Amisulpride injection is used to prevent and treat nausea and vomiting that may occur after surgery. Amisulpride is in a class of medications called dopamine receptor antagonists. It works by blocking the action of dopamine, a natural substance that may cause nausea and vomiting. Read the full Amisulpride Injection drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 12, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Amisulpride Injection Gemifloxacin Factive Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Gepirone Exxua An increased risk of QT interval prolongation and cardiac arrhythmias Details Amisulpride Injection Gepotidacin Blujepa An increased risk of QT interval prolongation Details Amisulpride Injection Givinostat Duvyzat Increased risk of QT interval prolongation and torsade de pointes Details Amisulpride Injection Glasdegib Daurismo Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Gonadorelin Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Goserelin Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Granisetron Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Halofantrine Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Haloperidol Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Histrelin Supprelin Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Hydroquinidine Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Hydroxychloroquine Plaquenil Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Hydroxyzine Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Ibutilide Corvert Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Iloperidone Fanapt Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Imipramine Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Inotuzumab Ozogamicin Besponsa Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Insulin Glargine, Recombinant Basaglar An increased risk of hypoglycemia Details Amisulpride Injection Insulin Icodec-Abae Awiqli Reduced efficacy of insulin icodec-abae Details Amisulpride Injection Isoflurane Fluriso An increased risk of QT interval prolongation and torsade de pointes Details Amisulpride Injection Itraconazole Sporanox Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Ivabradine Corlanor Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Ivosidenib Tibsovo Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Ketoconazole Extina Increased risk of QT interval prolongation Details Amisulpride Injection Lapatinib Tykerb Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Lefamulin Xenleta Increased risk of QT interval prolongation Details Amisulpride Injection Lenvatinib Lenvima Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Leuprolide Eligard Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Levodopa Inbrija Decreased efficacy of both agents Details Amisulpride Injection Levofloxacin Levaquin Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Lofexidine Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Lonafarnib Zokinvy An increased risk of QT interval prolongation and torsade de pointes Details Amisulpride Injection Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Amisulpride Injection Lumefantrine Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Macimorelin Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Mavorixafor Xolremdi An increased risk of QT interval prolongation and torsade de pointes Details Amisulpride Injection Mefloquine Lariam® Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Methadone Diskets Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Amisulpride Injection Methotrimeprazine Increased risk of serious ventricular arrhythmias such as torsades de pointes Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.